ZIVO BIOSCIENCE INC's ticker is ZIVO and the CUSIP is 98978N200. A total of 13 filers reported holding ZIVO BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,126 | -39.6% | 130,866 | +12.5% | 0.00% | – |
| Q2 2023 | $281,518 | -16.4% | 116,330 | +6.4% | 0.00% | – |
| Q1 2023 | $336,764 | +35.0% | 109,339 | +9.6% | 0.00% | – |
| Q4 2022 | $249,516 | -9.6% | 99,806 | +1.1% | 0.00% | – |
| Q3 2022 | $276,000 | -27.0% | 98,682 | +2.3% | 0.00% | – |
| Q2 2022 | $378,000 | +5.3% | 96,475 | +4.3% | 0.00% | – |
| Q1 2022 | $359,000 | +62.4% | 92,468 | +19.6% | 0.00% | – |
| Q4 2021 | $221,000 | – | 77,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX Topco Ltd | 22,976 | $66,000 | 0.04% |
| Verdence Capital Advisors LLC | 10,000 | $29,000 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 31 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 626 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,355 | $24,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 4,576 | $13,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 341,680 | $980,000 | 0.00% |
| Citadel Advisors | 25,483 | $73,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,219 | $3,000 | 0.00% |